WILLIAM FISHER to Pemetrexed
This is a "connection" page, showing publications WILLIAM FISHER has written about Pemetrexed.
Connection Strength
0.044
-
Randomized, double-blinded, multicenter, phase II study of pemetrexed, carboplatin, and bevacizumab with enzastaurin or placebo in chemona?ve patients with stage IIIB/IV non-small cell lung cancer: Hoosier Oncology Group LUN06-116. J Thorac Oncol. 2010 Nov; 5(11):1815-20.
Score: 0.024
-
Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study. J Thorac Oncol. 2009 Jan; 4(1):93-6.
Score: 0.021